Becton Dickinson EPS - Earnings per Share 2012-2026 | BDX
Becton Dickinson annual and quarterly earnings per share history from 2012 to 2026. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Becton Dickinson EPS for the quarter ending March 31, 2026 was $-1.11, a 203.74% decline year-over-year.
- Becton Dickinson EPS for the twelve months ending March 31, 2026 was $3.94, a 23.64% decline year-over-year.
- Becton Dickinson 2025 annual EPS was $5.82, a 0.68% decline from 2024.
- Becton Dickinson 2024 annual EPS was $5.86, a 18.62% increase from 2023.
- Becton Dickinson 2023 annual EPS was $4.94, a 15.99% decline from 2022.
| Becton Dickinson Annual EPS | |
|---|---|
| 2025 | $5.82 |
| 2024 | $5.86 |
| 2023 | $4.94 |
| 2022 | $5.88 |
| 2021 | $6.85 |
| 2020 | $2.71 |
| 2019 | $3.94 |
| 2018 | $0.60 |
| 2017 | $4.60 |
| 2016 | $4.49 |
| 2015 | $3.35 |
| 2014 | $5.99 |
| 2013 | $6.49 |
| 2012 | $5.59 |
| 2011 | $5.62 |
| Becton Dickinson Quarterly EPS | |
|---|---|
| 2026-03-31 | $-1.11 |
| 2025-12-31 | $1.34 |
| 2025-09-30 | $1.71 |
| 2025-06-30 | $2.00 |
| 2025-03-31 | $1.07 |
| 2024-12-31 | $1.04 |
| 2024-09-30 | $1.37 |
| 2024-06-30 | $1.68 |
| 2024-03-31 | $1.85 |
| 2023-12-31 | $0.96 |
| 2023-09-30 | $0.35 |
| 2023-06-30 | $1.36 |
| 2023-03-31 | $1.53 |
| 2022-12-31 | $1.70 |
| 2022-09-30 | $0.92 |
| 2022-06-30 | $1.18 |
| 2022-03-31 | $1.50 |
| 2021-12-31 | $2.28 |
| 2021-09-30 | $0.84 |
| 2021-06-30 | $1.72 |
| 2021-03-31 | $0.94 |
| 2020-12-31 | $3.35 |
| 2020-09-30 | $0.34 |
| 2020-06-30 | $0.97 |
| 2020-03-31 | $0.53 |
| 2019-12-31 | $0.87 |
| 2019-09-30 | $0.45 |
| 2019-06-30 | $1.51 |
| 2019-03-31 | $-0.07 |
| 2018-12-31 | $2.05 |
| 2018-09-30 | $-0.48 |
| 2018-06-30 | $2.03 |
| 2018-03-31 | $-0.19 |
| 2017-12-31 | $-0.76 |
| 2017-09-30 | $1.19 |
| 2017-06-30 | $-0.75 |
| 2017-03-31 | $1.58 |
| 2016-12-31 | $2.58 |
| 2016-09-30 | $0.07 |
| 2016-06-30 | $1.80 |
| 2016-03-31 | $1.56 |
| 2015-12-31 | $1.06 |
| 2015-09-30 | $0.78 |
| 2015-06-30 | $0.29 |
| 2015-03-31 | $1.08 |
| 2014-12-31 | $1.20 |
| 2014-09-30 | $1.52 |
| 2014-06-30 | $1.65 |
| 2014-03-31 | $1.45 |
| 2013-12-31 | $1.37 |
| 2013-09-30 | $0.45 |
| 2013-06-30 | $1.52 |
| 2013-03-31 | $1.39 |
| 2012-12-31 | $3.13 |
| 2012-09-30 | $1.40 |
| 2012-06-30 | $1.59 |
| 2012-03-31 | $1.39 |
| 2011-12-31 | $1.21 |
| 2011-09-30 | $1.35 |
| 2011-06-30 | $1.53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $43.913B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |